Peter Schierack

Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins

Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome

Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease

Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype

Autoimmunity in Crohn's Disease—A Putative Stratification Factor of the Clinical Phenotype

Role of F1C Fimbriae, Flagella, and Secreted Bacterial Components in the Inhibitory Effect of Probiotic Escherichia coli Nissle 1917 on Atypical Enteropathogenic E. coli Infection

Crohn’s disease specific pancreatic antibodies: clinical and pathophysiological challenges

Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA

Species-specific and pathotype-specific binding of bacteria to zymogen granule membrane glycoprotein 2 (GP2)

Glycoprotein 2 Antibodies in Crohn's Disease

New Platform Technology for Comprehensive Serological Diagnostics of Autoimmune Diseases